Vaxart (VXRT) Tops Q3 EPS by 3c

Vaxart (NASDAQ: VXRT) reported Q3 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $72.4 million versus the consensus estimate of $21.15 million.

For earnings history and earnings-related data on Vaxart (VXRT) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• HSBC Upgrades Sembcorp Industries (SCI:SP) to Buy
• Immix Biopharma (IMMX) Reiterated at Market Outperform by Citizens on Upcoming Milestones